Mary Beth DeLena Joins PepGen as General Counsel and Secretary
BOSTON, Jan. 17, 2024 (GLOBE NEWSWIRE) — PepGen Inc. (Nasdaq:PEPG), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and neurological diseases, today announced the expansion of its executive team with the appointment of Mary Beth DeLena as General Counsel and Secretary. Ms. DeLena joins PepGen with over 20 years of experience advising global life science companies in a broad range of strategic, transactional, and corporate matters with extensive experience in business development, finance, securities, corporate governance, employment and commercial law.
Related news for (PEPG)
- 24/7 Market News Snapshot 25 September, 2025 – PepGen Inc. Common Stock (NASDAQ:PEPG)
- PepGen Announces Pricing of $100 Million Public Offering
- Don’t Miss Out: MoBot’s Latest Stock Updates 09/25/25 07:00 AM
- Today’s Top Performers: MoBot’s Market Review 09/25/25 06:00 AM
- MoBot alert highlights: NASDAQ: OFAL, NASDAQ: PEPG, NASDAQ: XXII, NYSE: LAC, NYSE: ATCH (09/25/25 05:00 AM)